NASDAQ:BSTC BioSpecifics Technologies (BSTC) Stock Price, News & Analysis → They said crypto was dead. It went up 100X. (From InvestorPlace) (Ad) Free BSTC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$88.53▼$88.5350-Day Range$88.22▼$88.5352-Week Range$42.00▼$89.15VolumeN/AAverage Volume61,105 shsMarket Capitalization$650.25 millionP/E Ratio37.51Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get BioSpecifics Technologies alerts: Email Address Ad Monument Traders AllianceMake This $3 Trade the Instant the Opening Bell RingsSince the birth of Wall Street, one simple rule has remained the same.... Buy stocks that are cheap....When they’re on sale…. And when nobody else is looking…See Why This $3.00 Stock Could Hit $15.00 About BioSpecifics Technologies Stock (NASDAQ:BSTC)BioSpecifics Technologies Corp., a biopharmaceutical company, develops an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX and Xiapex brands. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, plantar fibromatosis, human lipoma, and uterine fibroids. The company has a development and license agreement with Endo Global Ventures. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Wilmington, Delaware.Read More Ad Colonial MetalsCentral Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. BSTC Stock News HeadlinesMarch 21, 2023 | bizjournals.comSilicon Valley Technology NewsSee More Headlines Receive BSTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioSpecifics Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/14/2020Today3/18/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryBiotechnology Current SymbolNASDAQ:BSTC CUSIP09093110 CIK875622 Webwww.biospecifics.com Phone302-842-8450FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$3.33 Trailing P/E Ratio37.51 Forward P/E Ratio61.91 P/E GrowthN/ANet Income$24.47 million Net Margins47.43% Pretax MarginN/A Return on Equity14.81% Return on Assets14.46% Debt Debt-to-Equity RatioN/A Current Ratio66.24 Quick Ratio66.24 Sales & Book Value Annual Sales$38.19 million Price / Sales17.03 Cash Flow$3.38 per share Price / Cash Flow26.18 Book Value$18.42 per share Price / Book4.81Miscellaneous Outstanding Shares7,345,000Free FloatN/AMarket Cap$650.25 million OptionableNot Optionable Beta0.24 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesDr. Ronald Law J.D. (Age 67)Ph.D., Sr. VP of Bus. Devel. Comp: $487.38kMr. Joseph Truitt (Age 55)CEO & Director Mr. Patrick C. Hutchison (Age 61)Chief Financial Officer Mr. Alex MonteithSr. VP & Chief Bus. OfficerCarl A. ValensteinCorp. Sec.Key CompetitorsOPKO HealthNASDAQ:OPKStemline TherapeuticsNASDAQ:STMLLexicon PharmaceuticalsNASDAQ:LXRXAkouosNASDAQ:AKUSAlbireo PharmaNASDAQ:ALBOView All Competitors BSTC Stock Analysis - Frequently Asked Questions How were BioSpecifics Technologies' earnings last quarter? BioSpecifics Technologies Corp. (NASDAQ:BSTC) announced its quarterly earnings results on Saturday, November, 14th. The biopharmaceutical company reported $0.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.70. The biopharmaceutical company had revenue of $11.26 million for the quarter, compared to the consensus estimate of $5.46 million. BioSpecifics Technologies had a net margin of 47.43% and a trailing twelve-month return on equity of 14.81%. What other stocks do shareholders of BioSpecifics Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioSpecifics Technologies investors own include AbbVie (ABBV), NVIDIA (NVDA), Pfizer (PFE), Biogen (BIIB), Johnson & Johnson (JNJ), Horizon Therapeutics Public (HZNP), Inovio Pharmaceuticals (INO), Intel (INTC), Bristol-Myers Squibb (BMY) and CRISPR Therapeutics (CRSP). This page (NASDAQ:BSTC) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSpecifics Technologies Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.